Cushing syndrome is a severe endocrine disorder of cortisol excess associated with major metabolic and cardiovascular sequelae. We recently identified somatic mutations in PRKACA, the gene encoding the catalytic (C) α subunit of protein kinase A (PKA), as being responsible for cortisol-producing adrenocortical adenomas (CPAs), which are a major cause of Cushing syndrome. In spite of previous studies on the two initially identified mutations (L206R, 199_200insW), the mechanisms of action of the clinically highly relevant PRKACA mutations remain poorly understood. Here, by investigating a large panel of PRKACA mutations, including all those identified so far in Cushing syndrome, we unexpectedly found that not all mutations interfere with the binding of regulatory (R) subunits as previously hypothesized. Because several mutations lie in a region of PKA Cα involved in substrate recognition, we investigated their consequences on substrate specificity by quantitative phosphoproteomics. We found that all three mutations analyzed (L206R, 200_201insV, and d244-248+E249Q) cause major changes in the preference of PKA for its targets, leading to hyperphosphorylation of several PKA substrates, most notably including histone H1.4 at Ser36, which is required for and promotes mitosis. This is reflected by a ninefold hyperphosphorylation of H1.4 in CPAs carrying the L206R mutation. Thus, our findings suggest that in addition to hampering binding to R subunits, PRKACA mutations act by altering PKA substrate specificity. These findings shed light on the molecular events leading to Cushing syndrome and illustrate how mutations altering substrate specificity of a protein kinase may cause human disease.
Pubmed ID: 30615103 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets PKA C-α
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis polyclonal targets FLAG
View all literature mentionsThis unknown targets RRXS*/T*
View all literature mentionsThis monoclonal targets PKARII beta
View all literature mentionsThis unknown targets Histone H1.4
View all literature mentionsThis monoclonal targets PKARI alpha
View all literature mentionsThis polyclonal targets Phospho-(Ser/Thr) PKA Substrate
View all literature mentionsThis unknown targets Phospho-Histone H1.4 (Ser35)
View all literature mentionsThis unknown targets Histone H1.4
View all literature mentionsThis polyclonal targets Phospho-(Ser/Thr) PKA Substrate
View all literature mentionsThis monoclonal targets PKARII beta
View all literature mentionsThis monoclonal targets PKARI alpha
View all literature mentionsThis polyclonal targets FLAG
View all literature mentionsThis polyclonal targets PKA C-α
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis unknown targets RRXS*/T*
View all literature mentionsThis unknown targets Phospho-Histone H1.4 (Ser35)
View all literature mentions